Trials / Completed
CompletedNCT04412980
Ionized Magnesium for Monitoring of Citrate-anticoagulated CVVHD
Importance of Ionized Magnesium Measurement for Monitoring of Continuous Venovenous Haemodialysis With Citrate Anticoagulation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
It has been reported in several studies that ionized hypomagnesemia is associated with higher morbidity and mortality rates. During continuous renal replacement therapy with regional citrate anticoagulation (CRRT-RCA), the loss of magnesium has been reported to not be covered by magnesium concentration in ordinary dialysis fluid. This may lead to ionized hypomagnesemia. However the incidence of ionized hypomagnesemia in patients requiring CRRT-RCA remains unclear and need to be estimated to determine if ionized magnesium monitoring could be of interest. This study aim to assess the incidence of ionized hypomagnesemia induced by CRRT-RCA.
Conditions
Timeline
- Start date
- 2020-05-01
- Primary completion
- 2020-10-01
- Completion
- 2020-11-23
- First posted
- 2020-06-02
- Last updated
- 2020-11-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04412980. Inclusion in this directory is not an endorsement.